Ticker League

Revenue for IDEXX Laboratories (IDXX) 1991-2026

Latest filings through · Reported

Metric

TTM

$4.45B

YoY change

+10.4%

5Y CAGR

+9.7%

Peak year (FY2025)

$4.3B

Revenue history chart for IDEXX Laboratories (IDXX) from 2016 to 2025

Latest: $4.3B

Revenue growth chart for IDEXX Laboratories (IDXX) from 2016 to 2025

Latest: +10.4%

Revenue history table for IDEXX Laboratories (IDXX) from 1991 to 2025

  • FY2025$4.3B+10.4%
  • FY2024$3.9B+6.5%
  • FY2023$3.66B+8.7%
  • FY2022$3.37B+4.7%
  • FY2021$3.22B+18.8%
  • FY2020$2.71B+12.5%
  • FY2019$2.41B+8.8%
  • FY2018$2.21B+12.4%
  • FY2017$1.97B+10.9%
  • FY2016$1.78B+10.8%
  • FY2015$1.6B+7.8%
  • FY2014$1.49B+7.9%
  • FY2013$1.38B+6.5%
  • FY2012$1.29B+6.1%
  • FY2011$1.22B+10.4%
  • FY2010$1.1B+7.0%
  • FY2009$1.03B+0.7%
  • FY2008$1.02B+11.0%
  • FY2007$923M+24.8%
  • FY2006$739M+15.8%
  • FY2005$638M+16.2%
  • FY2004$549M+15.4%
  • FY2003$476M+15.3%
  • FY2002$413M+6.9%
  • FY2001$386M+5.1%
  • FY2000$367M+3.2%
  • FY1999$356M+11.3%
  • FY1998$320M+21.6%
  • FY1997$263M-1.8%
  • FY1996$268M+41.9%
  • FY1995$189M+49.2%
  • FY1994$126M+35.8%
  • FY1993$93.1M+61.4%
  • FY1992$57.7M+89.2%
  • FY1991$30.5M—

Revenue values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Revenue at IDEXX Laboratories (IDXX)

According to IDEXX Laboratories's latest reported financial statements, the company's current revenue (TTM) is $4.45B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

2025's annual revenue for IDEXX Laboratories (IDXX) came in at $4.3B – grew 10.4% year-over-year.

IDEXX Laboratories revenue has grown for 28 consecutive years, with a +9.7% compound annual growth rate over 2020–2025 (5 years).

Across the available history, revenue reached its high of $4.3B in 2025 and its low of $30.5M in 1991.

IDEXX Laboratories Revenue by Year

IDEXX Laboratories Revenue 2025: $4.3B

IDEXX Laboratories posted revenue of $4.3B in 2025, grew 10.4% from 2024. This figure represents the highest annual value in the available history.

IDEXX Laboratories Revenue 2024: $3.9B

In 2024, IDEXX Laboratories reported revenue of $3.9B, grew 6.5% from 2023.

IDEXX Laboratories Revenue 2023: $3.66B

IDEXX Laboratories revenue in 2023 was $3.66B, grew 8.7% from 2022.

IDEXX Laboratories Revenue 2022: $3.37B

2022's revenue for IDEXX Laboratories came in at $3.37B, edged up 4.7% from 2021.

IDEXX Laboratories Revenue 2021: $3.22B

IDEXX Laboratories revenue in 2021 was $3.22B.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers by Revenue

Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest revenue

Frequently asked questions

Trains Profitability

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.